INNOVATIVE KEYS TO
HEALTH AND WELLBEING
New Marketing Authorization Approval in The Philippines for new indication of locally advanced unresectable or metastatic pancreatic cancer.
Innokeys | September 18th, 2020

On 18 Sep 2020, Philippines FDA approved new marketing authorization for indication locally advanced unresectable or metastatic pancreatic cancer for nimotuzumab. This indication is added to previous indications: gliomas in adults and children, locally advanced SCCHN.